BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17060520)

  • 1. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
    Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus.
    Chung DH; Sun Y; Parker WB; Arterburn JB; Bartolucci A; Jonsson CB
    J Virol; 2007 Nov; 81(21):11722-9. PubMed ID: 17699579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
    Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
    Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
    Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.
    Khan M; Dhanwani R; Patro IK; Rao PV; Parida MM
    Antiviral Res; 2011 Jan; 89(1):1-8. PubMed ID: 21070810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro.
    Smee DF; Bray M; Huggins JW
    Antivir Chem Chemother; 2001 Nov; 12(6):327-35. PubMed ID: 12018677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
    Leyssen P; De Clercq E; Neyts J
    Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolic acid inhibits avian reovirus replication.
    Robertson CM; Hermann LL; Coombs KM
    Antiviral Res; 2004 Oct; 64(1):55-61. PubMed ID: 15451179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity.
    Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
    Cell Growth Differ; 1990 Jun; 1(6):259-70. PubMed ID: 1980599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of mycophenolic acid on the replication of infectious pancreatic necrosis virus and viral hemorrhagic septicemia virus.
    Marroquí L; Estepa A; Perez L
    Antiviral Res; 2008 Dec; 80(3):332-8. PubMed ID: 18721827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and antiviral activity of ribavirin.
    Parker WB
    Virus Res; 2005 Feb; 107(2):165-71. PubMed ID: 15649562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
    Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
    Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.
    Hermann LL; Coombs KM
    J Virol; 2004 Jun; 78(12):6171-9. PubMed ID: 15163710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitions of human parainfluenza virus type 2 replication by ribavirin and mycophenolate mofetil are restored by guanosine and S-(4-nitrobenzyl)-6-thioinosine.
    Uematsu J; Sakai-Sugino K; Kihira-Nakanishi S; Yamamoto H; Hirai K; Kawano M; Nishio M; Tsurudome M; O'Brien M; Komada H
    Drug Discov Ther; 2019; 13(6):314-321. PubMed ID: 31956229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro study of antiviral activity of mycophenolic acid on Brazilian orthobunyaviruses.
    Livonesi MC; Moro de Sousa RL; Moraes Figueiredo LT
    Intervirology; 2007; 50(3):204-8. PubMed ID: 17283446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of T-705 against influenza virus.
    Furuta Y; Takahashi K; Kuno-Maekawa M; Sangawa H; Uehara S; Kozaki K; Nomura N; Egawa H; Shiraki K
    Antimicrob Agents Chemother; 2005 Mar; 49(3):981-6. PubMed ID: 15728892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.